Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
J Toxicol Sci ; 34 Suppl 1: SP147-55, 2009.
Article in English | MEDLINE | ID: mdl-19265281

ABSTRACT

To investigate the optimal administration period for evaluating ovarian toxicity that reflects abnormal female fertility in the repeated dose toxicity study, atrazine, a potent herbicide with endocrine-disrupting activity, was administered to female Sprague-Dawley (Slc:SD) rats for two or four weeks at doses of 3, 30 or 300 mg/kg for the repeated dose toxicity study, and at doses of 3, 30 or 100 mg/kg for the female fertility study from two weeks before mating to Day 7 of gestation. In the two-week repeated dose toxicity study, prolongation of diestrus and histopathological findings such as loss of the currently formed corpora lutea, decrease in the numbers of previously formed corpora lutea, increase in large-sized atretic follicles, and swelling of the previously formed luteal cells were observed in the 300 mg/kg group, suggesting that atrazine had an anovulatory effect through suppression of the luteinizing hormone surge. In the female fertility study, copulation failure caused by prolongation of diestrus was observed in one animal in the 100 mg/kg group, which could be due to the anovulatory effect of atrazine. It is demonstrated that the effect of atrazine on female fertility can be assessed by detailed histopathological examination of ovaries in a two-week repeated dose toxicity study, provided the appropriate dose levels are selected.


Subject(s)
Atrazine/toxicity , Fertility/drug effects , Herbicides/toxicity , Ovary/drug effects , Toxicity Tests/methods , Animals , Atrazine/administration & dosage , Body Weight/drug effects , Copulation/drug effects , Corpus Luteum/drug effects , Corpus Luteum/metabolism , Corpus Luteum/pathology , Drug Administration Schedule , Estrous Cycle/drug effects , Female , Herbicides/administration & dosage , Japan , Male , Organ Size/drug effects , Ovarian Follicle/drug effects , Ovarian Follicle/metabolism , Ovarian Follicle/pathology , Ovary/pathology , Ovary/physiopathology , Pregnancy , Proliferating Cell Nuclear Antigen/metabolism , Public-Private Sector Partnerships , Rats , Rats, Sprague-Dawley , Societies, Scientific , Weight Gain/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...